Metabolic Evaluation for Nephrocalcinosis
All patients with nephrocalcinosis require a comprehensive metabolic workup to identify the underlying cause, as nephrocalcinosis implies an underlying metabolic disorder such as renal tubular acidosis type 1, primary hyperparathyroidism, or primary hyperoxaluria that requires specific treatment. 1
Initial Serum Testing
Obtain the following serum parameters to identify common metabolic and endocrine causes 2, 3:
- Serum calcium (to detect hypercalcemia suggesting primary hyperparathyroidism) 1, 2, 3
- Serum phosphate (to evaluate for hypophosphatemic disorders) 2, 3
- Serum creatinine (to assess renal function) 2, 3
- Intact parathyroid hormone (PTH) (primary hyperparathyroidism should be suspected when serum calcium is high or high-normal) 1, 2, 3
- 25-OH vitamin D levels (to evaluate for vitamin D disorders) 2, 3
- Serum alkaline phosphatase (to evaluate for bone disease) 2
Acid-Base and Electrolyte Assessment
Measure the following to detect renal tubular acidosis and electrolyte disorders 1:
- Acid-base status (either by blood gas or venous total CO₂) 1
- Serum electrolytes including sodium, chloride, potassium, and magnesium 1
- Serum bicarbonate (to detect metabolic acidosis) 1
Urinary Metabolic Testing
Perform one or two 24-hour urine collections (two collections preferred) analyzed for the following parameters 1:
- Total urine volume 1
- Urine pH 1
- Urinary calcium 1
- Urinary oxalate (primary hyperoxaluria should be suspected when urinary oxalate exceeds 75 mg/day in adults without bowel dysfunction) 1
- Urinary uric acid 1
- Urinary citrate 1
- Urinary sodium 1
- Urinary potassium 1
- Urinary creatinine 1
If 24-hour urine collection is not feasible, obtain a spot urine calcium-to-creatinine ratio to assess for hypercalciuria, the most common metabolic risk factor 1, 2, 3, 4.
Imaging Studies
- Renal ultrasonography to confirm nephrocalcinosis extent and distribution, monitor progression, and evaluate for kidney stones or obstructive uropathy 1, 2, 3
- Perform follow-up ultrasound every 12-24 months to assess progression 1, 3
Stone Analysis
When kidney stones are available, obtain stone composition analysis at least once, as specific compositions (uric acid, cystine, struvite) implicate specific metabolic or genetic abnormalities 1, 3. Calcium oxalate monohydrate stones with white or pale yellow color and disorganized internal structure suggest primary hyperoxaluria 1.
Genetic Testing
Recommend genetic testing when clinical and biochemical findings suggest inherited tubular disorders such as 1:
- Bartter syndrome (hypokalemic metabolic alkalosis, hypercalciuria, nephrocalcinosis, elevated renin/aldosterone) 1
- Primary hyperoxaluria (markedly elevated urinary oxalate >75 mg/day, recurrent calcium oxalate stones, early-onset disease) 1
- Dent disease (hypercalciuria, low molecular weight proteinuria, X-linked inheritance) 5, 6
- Distal renal tubular acidosis (hyperchloremic metabolic acidosis, alkaline urine pH >5.5, hypercalciuria) 4, 5
Common Underlying Causes to Evaluate
The most frequent metabolic disorders causing nephrocalcinosis include 4, 5:
- Idiopathic hypercalciuria (38.4% of cases in pediatric series) 4
- Distal renal tubular acidosis (23.9% of systemic diseases) 4
- Primary hyperoxaluria (19.6% of systemic diseases) 4
- Bartter syndrome (15.3% of systemic diseases) 4
Special Considerations and Pitfalls
- Do not restrict dietary calcium excessively without documented hypercalciuria, as this can worsen bone disease and paradoxically increase stone risk 1, 3
- Avoid vitamin D supplementation in patients with hypercalcemia or hypercalciuria until the underlying cause is identified and treated 3
- In patients with X-linked hypophosphatemia receiving phosphate and vitamin D therapy, monitor closely as these medications can cause or worsen nephrocalcinosis 2, 7
- Failure to identify the underlying cause leads to ineffective management and disease progression 3
- Measure urinary cystine if cystinuria is suspected based on family history or stone composition 1